Pharmacists tasked with choosing manufacturing partners for generic medications, outsourced compounded medications and other products critical to patient care should be familiar with how these facilities navigate FDA inspections. Such due diligence can go a long way toward ensuring product integrity and safety, speakers noted during the 2024 Traceability Seminar hosted by the Healthcare Distribution Alliance, in Washington, D.C.
Facilities that excel in this setting adopt the